Search for Clinical Trial Results

Sponsored By

Abdominal Neoplasms - 350 Studies Found

Status Study
Completed Study Name: Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Condition:
  • Fallopian Tube Cancer
  • Ovarian Cancer
  • Peritoneal Cavity Can
    Date: 2005-09-20
    Interventions:
    • Drug: gemcitabine hydrochloride
    • Drug: topo
Completed Study Name: Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
Condition:
  • Fallopian Tube Cancer
  • Ovarian Cancer
  • Peritoneal Cavity Can
    Date: 2005-09-20
    Interventions:
    • Biological: pegfilgrastim
    • Drug: carboplati
Completed Study Name: An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
Condition:
  • Genital Neoplasms, Female
  • Fallopian Tube Neoplasms
  • Ovarian
    Date: 2005-09-12
    Interventions:
    • Drug: Gemcitabine

Completed Study Name: A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.
Condition:
  • Genital Neoplasms, Female
  • Fallopian Tube Neoplasms
  • Ovarian
    Date: 2005-09-12
    Interventions:
    • Drug: Gemcitabine
    • Drug: liposomal doxorubi
Completed Study Name: Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse
Condition:
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Malignant Tumor of Pe
    Date: 2005-09-12
    Interventions:
    • Drug: Paclitaxel
    • Drug: Topotecan
Completed Study Name: Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients
Condition:
  • Ovarian Cancer
  • Fallopian Tube Neoplasms
  • Peritoneal Neoplas
    Date: 2005-09-12
    Interventions: Biological: anti-EpCAM x anti-CD3 (removab)
Completed Study Name: Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma
Condition:
  • Ovarian Carcinoma
  • Peritoneal Neoplasms

Date: 2005-09-09
Interventions: Drug: Docetaxel and Gemcitabine Docetaxel 75 mg/m2 IV over 15-30 minutes on day 1 followed by Gemcitabin
Completed Study Name: Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
Condition:
  • Fallopian Tube Cancer
  • Ovarian Cancer
  • Primary Peritoneal Ca
    Date: 2005-08-29
    Interventions:
    • Drug: carboplatin
    • Drug: docetaxel
Completed Study Name: Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
Condition:
  • Primary Peritoneal Cavity Cancer
  • Recurrent Ovarian Epithelial Cancer

Date: 2005-08-16
Interventions: Drug: vorinostat Given orally Other Names:
Completed Study Name: Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Condition:
  • Fallopian Tube Cancer
  • Primary Peritoneal Cavity Cancer
  • Rec
    Date: 2005-08-02
    Interventions:
    • Biological: bevacizumab Given

<<< Previous | Next >>>